Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A PHASE I STUDY WITH AN EXPANSION COHORT OF THE COMBINATION OF IPILIMUMAB AND BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A TRIAL OF THE ECOG-ACRIN CANCER RESEARCH GROUP (E4412) Diefenbach, C. M., Hong, F., Ambinder, R. F., Cohen, J. B., Robertson, M. J., Fenske, T. S., Advani, R., Kahl, B. S., Ansell, S. FERRATA STORTI FOUNDATION. 2016: 44–45
View details for Web of Science ID 000392549000106